RES hyperphagocytosis by rats with streptozotocin-induced diabetes mellitus.
In contrast to previous studies of neutrophils from diabetic animals and humans in vitro and of macrophages from diabetic humans in vivo, which reported phagocytic depression, reticuloendothelial system (RES) hyperphagocytosis of colloidal carbon was observed in rats at 14 and 28 days after diabetes induction with streptozotocin (STZ). Carbon clearance half times were significantly enhanced to 6.3 +/- 0.79 and 8.1 +/- 1.04 min at 14 and 28 days post-STZ, respectively, compared with the nondiabetic value (12.7 +/- 0.98 min). The severity of uncontrolled STZ-induced diabetes in rats was confirmed by significant hypoinsulinemia, hyperglucagonemia, hyperglycemia, and hyperlipidemia. Although body weights of STZ-diabetic animals declined progressively, liver weights as a percent of body weight increased above the control value at 14 and 28 days post-STZ. In fact, expression of carbon phagocytosis as the corrected phagocytic index, which accounts for changes in liver and spleen weights relative to body weight, eliminated the significant difference between STZ-diabetic and nondiabetic animals. Antibiotic treatment of diabetic rats failed to alter the hyperphagocytosis, implying that a chronic bacterial infection was not the cause of phagocytic stimulation. Daily insulin replacements, but not a single large insulin dose to 14-day post-STZ rats, reversed the enhanced phagocytosis of colloidal carbon.
D000818:Animals; D001835:Body Weight; D002244:Carbon; D003864:Depression, Chemical; D003921:Diabetes Mellitus, Experimental / Q000276:immunology*; D007328:Insulin / Q000494:pharmacology; D007728:Kupffer Cells / Q000276:immunology; D008099:Liver / Q000033:anatomy & histology; D008264:Macrophages / Q000276:immunology*; D008297:Male; D009929:Organ Size; D010587:Phagocytosis / Q000187:drug effects; D051381:Rats; D013311:Streptozocin
D007328:Insulin; D013311:Streptozocin; D002244:Carbon